+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are studying the use of transcranial direct current stimulation tDCS, a technique that uses low-intensity electrical currents to influence brain activity, for treating moderate to severe depression. This study aims to compare how effective tDCS is when performed at home versus in a hospital setting, focusing on reducing depressive symptoms six weeks after treatment. The trial also highlights the importance of regular clinical monitoring to ensure safety and proper treatment adherence. Participants are randomly assigned to one of two groups one group receives tDCS treatment at the hospital under nursing supervision, while the other performs self-administered tDCS at home with remote nursing oversight through a digital app that monitors treatment and compliance. The treatment involves 20 sessions over 10 working days, with two 30-minute sessions per day at 2 mA. The study also includes questionnaires, interviews, and monitoring to assess the experience and impact of the treatments. Throughout the study, participants complete various assessments, including depression rating scales and quality of life measures, before, immediately after, and six weeks post-treatment. Nurses provide guidance on device use during hospital visits, and remote monitoring supports adherence for home treatments. Researchers evaluate effectiveness, safety, patient self-reports, and the financial and practical aspects of delivering tDCS in both settings. The study lasts about two months, with follow-ups to measure lasting effects and implementation factors.

Age: 18Years +All GendersPhase Not Applicable
6 locations
S

Actively Recruiting

Schizophrenia, affecting about 0.7% of the population, often leads to poor insight and medication compliance, resulting in relapses and a reduced quality of life. Researchers are evaluating an individual early psychoeducation program called PEPITS for inpatients with schizophrenia or related disorders. The study aims to see if PEPITS can reduce relapses, improve medication adherence and insight, and enhance quality of life. The PEPITS program is delivered by nurses during the initial hospitalization phase and consists of three parts an introduction session, sessions focused on understanding the illness and care, and sessions on recovery and building coping skills. Participants are randomly assigned to either the PEPITS program or to usual psychiatric care without PEPITS. Participants will be monitored from the start of the study until one year after randomization to assess changes in insight, quality of life, and medication compliance. Additional evaluations include quality of life and psychological well-being at work, job satisfaction, self-efficacy, and work commitment over six months. The study involves regular assessments to track these outcomes and better understand the programs impact.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
11 locations